Consumer language guides help patients understand that generic drugs are just as effective as brand-name ones-same active ingredient, same results, much lower cost. Learn how plain-language tools are breaking down myths and boosting adherence.
Bioequivalence studies for generic drugs have historically excluded women and older adults. New regulations now require more representative testing to ensure safety and effectiveness across all users.
Generic and brand-name drugs have the same active ingredients and carry the same risk of drug interactions. The FDA and major studies confirm they're equally safe and effective. Here's what you really need to know.
Prescribers remain cautious about substituting generic drugs for narrow therapeutic index medications due to risks of instability and adverse effects. Despite FDA assurances, doctors prioritize patient safety through careful monitoring and controlled switching.
Generic drugs save the U.S. healthcare system nearly $500 billion annually by providing the same effectiveness as brand-name medications at a fraction of the cost. Discover how generics and biosimilars are reshaping drug pricing and what you can do to save money.
Despite being just as safe and effective as brand-name drugs, generics face widespread public mistrust fueled by misleading media coverage. Learn how news stories shape perceptions - and what can be done to restore confidence.
The Hatch-Waxman Act of 1984 created the modern system for generic drugs in the U.S., balancing innovation incentives with affordable access. It cut approval costs by 90%, boosted generic use to 90% of prescriptions, and sparked ongoing debates over drug pricing.
Generic medications cost far less than brand-name drugs because they don't need to recoup R&D costs or run expensive marketing campaigns. They're just as safe and effective, and they save patients and insurers hundreds of billions each year.